TABLE.
A. | NAT/NP | ||
---|---|---|---|
Positive | Negative | ||
ID NOW COVID-19 | Positive | 2 | 3 |
Negative | 2 | 1093 | |
Sensitivity | 50% (95% CI, 6.8 to 93.2) | ||
Specificity | 99.7% (95% CI, 99.2 to 99.9) | ||
Positive likelihood ratio | 182.7 (95% CI, 40.9 to 815.2) | ||
Negative likelihood ratio | 0.50 (95% CI, 0.19 to 1.34) | ||
Positive predictive value | 40.0 (95% CI, 13.0 to 74.8) | ||
Negative predictive value | 99.8 (95% CI, 99.5 to 99.9) |
B. | NAT/NP | ||
---|---|---|---|
Positive | Negative (considered negative if Ct >25) | ||
ID NOW COVID-19 performance with modified definitions* | Positive (on repeat sample) | 2 | 0 |
Negative (not repeated) | 0 | 1,098 | |
Sensitivity | 100% (95% CI, 15.8 to 100) | ||
Specificity | 100% (95% CI, 99.7 to 100) | ||
Positive predictive value | 100% (34.2–100%) | ||
Negative predictive value | 100% (99.7–100%) |
* ID NOW COVID-19 considered positive only after two positive results on separate samples and laboratory NAT considered negative if Ct > 25
CI = confidence interval; Ct = cycle threshold; NAT/NP = nucleic acid testing/nasopharyngeal
A) Samples with single ID NOW COVID-19 test; B) Samples with positives repeated by ID NOW COVID-19